Two Sigma Investments’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-30,551
| Closed | -$378K | – | 4106 |
|
|
2025
Q3 | $378K | Buy |
30,551
+5,160
| +20% | +$60.5K | ﹤0.01% | 3116 |
|
|
2025
Q2 | $293K | Sell |
25,391
-26,769
| -51% | -$318K | ﹤0.01% | 2800 |
|
|
2025
Q1 | $782K | Sell |
52,160
-32,117
| -38% | -$538K | ﹤0.01% | 2311 |
|
|
2024
Q4 | $1.46M | Buy |
84,277
+8,957
| +12% | +$173K | ﹤0.01% | 1933 |
|
|
2024
Q3 | $1.4M | Buy |
+75,320
| New | +$1.51M | ﹤0.01% | 1903 |
|
|
2024
Q2 | – | Sell |
-29,800
| Closed | -$509K | – | 3067 |
|
|
2024
Q1 | $509K | Sell |
29,800
-32,660
| -52% | -$514K | ﹤0.01% | 2326 |
|
|
2023
Q4 | $1.1M | Buy |
+62,460
| New | +$1.26M | ﹤0.01% | 2015 |
|
|
2023
Q1 | – | Sell |
-14,545
| Closed | -$295K | – | 2986 |
|
|
2022
Q4 | $295K | Sell |
14,545
-21,667
| -60% | -$420K | ﹤0.01% | 2256 |
|
|
2022
Q3 | $488K | Buy |
+36,212
| New | +$610K | ﹤0.01% | 1791 |
|
|
2022
Q2 | – | Sell |
-15,329
| Closed | -$485K | – | 2564 |
|
|
2022
Q1 | $485K | Sell |
15,329
-119,950
| -89% | -$3.36M | ﹤0.01% | 2029 |
|
|
2021
Q4 | $3.02M | Sell |
135,279
-17,025
| -11% | -$444K | 0.01% | 1569 |
|
|
2021
Q3 | $4.23M | Buy |
+152,304
| New | +$4.64M | 0.01% | 1360 |
|
|
2021
Q2 | – | Sell |
-22,458
| Closed | -$647K | – | 4100 |
|
|
2021
Q1 | $647K | Buy |
+22,458
| New | +$767K | ﹤0.01% | 2686 |
|
|
2020
Q2 | – | Sell |
-146,544
| Closed | -$1.51M | – | 3003 |
|
|
2020
Q1 | $1.51M | Buy |
146,544
+34,834
| +31% | +$974K | 0.01% | 1129 |
|
|
2019
Q4 | $4.21M | Buy |
111,710
+100,334
| +882% | +$4.51M | 0.01% | 1072 |
|
|
2019
Q3 | $530K | Sell |
11,376
-10,920
| -49% | -$508K | ﹤0.01% | 2513 |
|
|
2019
Q2 | $1.17M | Buy |
+22,296
| New | +$1.31M | ﹤0.01% | 1824 |
|
|
2019
Q1 | – | Sell |
-109,200
| Closed | -$7.32M | – | 3068 |
|
|
2018
Q4 | $6.51M | Buy |
+109,200
| New | +$9.42M | 0.03% | 681 |
|
|
2018
Q2 | – | Sell |
-75,371
| Closed | -$9.17M | – | 3350 |
|
|
2018
Q1 | $8.16M | Buy |
+75,371
| New | +$8.34M | 0.03% | 686 |
|
|
2016
Q4 | – | Sell |
-8,104
| Closed | -$897K | – | 3135 |
|
|
2016
Q3 | $910K | Buy |
8,104
+6,004
| +286% | +$692K | ﹤0.01% | 2023 |
|
|
2016
Q2 | $260K | Buy |
+2,100
| New | +$254K | ﹤0.01% | 2630 |
|
|
2015
Q4 | – | Sell |
-3,900
| Closed | -$446K | – | 2690 |
|
|
2015
Q3 | $389K | Buy |
+3,900
| New | +$424K | ﹤0.01% | 1659 |
|
|
2013
Q3 | – | Sell |
-21,674
| Closed | -$3.29M | – | 1859 |
|
|
2013
Q2 | $3.29M | Buy |
+21,674
| New | +$3.07M | 0.02% | 676 |
|
Other funds holding CLB
AI
DGI
Two Sigma Investments's CLB Position: Q4 2025 in Review
Two Sigma Investments sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 30,551 shares — an estimated $378K sold.
Two Sigma Investments first reported a position in CLB in Q2 2013 and held it in 23 quarters. The position peaked at $8.16M in Q1 2018. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.
- Two Sigma Investments reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
- Two Sigma Investments sold 30,551 Core Laboratories shares in Q4 2025, an estimated $378K.
- Two Sigma Investments first reported a position in Core Laboratories in Q2 2013 and held it in 23 quarters.
- Two Sigma Investments's Core Laboratories position peaked at $8.16M in Q1 2018.
- 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.
Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.